HDAC-4 expression was mostly correlated with clinicopathological parameters, being associated with lower FIGO stage and tumor T-category as well as the absence of lymph node metastasis or distant metastasis. Here, HDAC4 is linked to metastatic malignant neoplasm in the lymph nodes.